beta-glucan

Overview

Beta-glucan (β-glucan) is a naturally occurring polysaccharide composed of glucose monomers linked by β-glycosidic bonds, found abundantly in the cell walls of fungi, yeast, cereals, and certain bacteria. Structurally, fungal and yeast β-glucans are characterized by β-1,3-linked glucose backbones with β-1,6-linked side chains, a configuration that confers both rigidity and biological activity. As a bioactive compound, β-glucan is recognized primarily for its immunomodulatory and antioxidant properties, acting through pattern recognition receptors — most notably Dectin-1 on innate immune cells — to activate macrophages, dendritic cells, and natural killer cells. This receptor-mediated signaling drives downstream immune cascades that enhance phagocytosis, cytokine production, and adaptive immune priming, positioning β-glucan as a broadly relevant therapeutic agent across oncology, infectious disease, and inflammatory conditions.

Beyond immune activation, β-glucan exhibits cytoprotective properties that extend to hematologic and metabolic contexts. Its ability to modulate lipid-hormone pathways, regulate antigen-presenting cells (APCs), and influence hematopoietic progenitor programming makes it a compound of significant pharmacological breadth. Sourced from organisms ranging from medicinal mushrooms such as Ganoderma lucidum to plants such as Prunus bokharensis, β-glucan occupies an expanding role in both nutraceutical science and drug development, with growing interest in conjugated or chemically modified forms designed to enhance targeting precision and therapeutic potency.

Focus of Latest Publications

Recent literature has positioned β-glucan at the intersection of oncology, immunology, gastroenterology, and antifungal vaccine development, reflecting the compound's multifunctional biological profile.

Cancer and Hepatocellular Carcinoma A 2026 study published in Cancer Chemotherapy and Pharmacology examined β-glucan's anticancer activity in a rat model of non-alcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC), a disease context involving liver cancer driven by metabolic and inflammatory dysregulation. Despite the compound's well-documented antioxidant and immunomodulatory properties, the authors noted that its specific role in NASH-associated HCC had remained insufficiently explored. The study investigated how β-glucan's modulation of apoptotic markers — including active cysteine-aspartic acid protease 3 (caspase-3) and B-cell lymphoma 2 (Bcl-2) — might contribute to tumor suppression, providing mechanistic evidence that β-glucan may counteract the pro-survival signaling that characterizes liver cancer progression.

Immunomodulation, Melanoma, and Erythroprotection Research published in Computers in Biology and Medicine (2026) focused on β-glucan derived from Prunus bokharensis, characterizing it through high-resolution mass spectrometry and computational approaches. The study reported that this polysaccharide exerts both cytoprotective and immunomodulatory effects, with identified multi-target interactions relevant to melanoma and hematologic conditions. Of particular note was the compound's capacity to regulate lipid-hormone axes, suggesting a mechanism by which β-glucan may influence tumor microenvironments beyond direct immune activation. The computational analysis involving bovine serum albumin as a carrier model further illuminated the pharmacokinetic behavior of the compound.

Inflammatory Bowel Disease and Monocyte Plasticity A study published in eLife (2026) demonstrated that pretreatment with β-glucan reprogrammed bone marrow hematopoietic progenitors and peripheral monocytes, producing a profound shift in monocyte plasticity that significantly reduced the severity of dextran sulfate sodium (DSS)-induced colitis in a murine model. RNA sequencing was employed to characterize the transcriptional reprogramming in these immune cell populations, revealing that β-glucan's protective effect in inflammatory bowel disease operates at the level of trained immunity — reshaping the epigenetic and functional landscape of myeloid progenitors prior to inflammatory challenge.

Antifungal Vaccine Development Research in Chemistry (Weinheim, 2026) explored surface-exposed β-glucans of Candida albicans as targets for vaccine development. The study employed heat-killed C. albicans (HKCA) as an immunogenic scaffold and developed a redox-responsive vaccine conjugate (β-glucans-BSA-L2-Rha) utilizing a disulfide linker to enable controlled antigen release within the reducing environment of the phagosome. This approach aimed to recruit endogenous antibodies and potentiate antifungal immunity, positioning β-glucan not only as an immune activator but as a structural antigen for next-generation vaccine platforms.

Gut Microbiota and Ganoderma lucidum A study in Food Research International (2026) evaluated extracts of Ganoderma lucidum (Reishi mushroom), finding that β-glucans — alongside ganoderic acids — mediate the mushroom's immunoregulatory effects through multiple pathways. Using an in vitro gastrointestinal digestion model, the study assessed digestion kinetics and gut microbiota modulation, demonstrating that β-glucans from this medicinal-edible fungus survive partial digestion and exert downstream effects on immune signaling through interactions with gut-associated immune tissues.

Anthocyanin Stabilization A study in Food Chemistry (2026) examined the copigmentation effects of various carbohydrates — including β-glucan (β-GC) — on the thermal and color stability of mulberry anthocyanins. While β-cyclodextrin (β-CD) exhibited the strongest protective effect, β-glucan demonstrated meaningful stabilizing activity, suggesting a role in food science applications where polysaccharide-pigment interactions can extend the functional shelf-life of bioactive food components.

Key Publications

Jun Evaluation of anticancer activity of beta glucan in non-alcoholic steatohepatitis associated hepatocellular carcinoma in rats. (Cancer chemotherapy and pharmacology, 2026, PMID 42236616): "Despite known antioxidant and immunomodulatory properties, the role of beta-glucan in NASH-associated HCC remains insufficiently explored."
Jun Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis. (eLife, 2026, PMID 42220316): "In our study, pretreatment with β-glucan reprogrammed bone marrow hematopoietic progenitors and peripheral monocytes, inducing a profound shift in monocyte plasticity and significantly reducing the severity of dextran sulfate sodium (DSS)-induced colitis."
Jun Integrated computational and structural understanding of Prunus bokharensis-derived β-Glucan: HRMS, network pharmacology, docking, and MD simulations to discover multi-target interactions for immunomodulation, antimelanoma lipid-hormone axis modulation, and erythroprotection. (Computers in biology and medicine, 2026, PMID 42054915): "β-Glucan, which is a type of polysaccharide, provides both cytoprotective effects and immunomodulatory effects, which scientists can use to develop treatments for hematologic conditions and melanoma through their ability to regulate lipid-hormone pathways."
May A Redox-Responsive β-Glucan-Based Vaccine Recruiting Endogenous Antibodies to Potentiate Antifungal Immunity. (Chemistry (Weinheim an der Bergstrasse, Germany), 2026, PMID 41816982): "Surface-exposed β-glucans of C. albicans have been identified as promising targets for antifungal vaccine development."
May Insights into the copigmentation effect and mechanism of five carbohydrates on thermal and color stability of mulberry anthocyanins. (Food chemistry, 2026, PMID 41747550): "β-CD exhibited the strongest protective effect, followed by CS and β-GC."
May Comprehensive evaluation of Ganoderma lucidum extracts: digestion kinetics, gut microbiota modulation, and immunoregulatory mechanisms. (Food research international (Ottawa, Ont.), 2026, PMID 41794511): "Ganoderma lucidum (Reishi mushroom) exhibits medicinal-edible functionality mediated by bioactive components such as β-glucans and ganoderic acids that regulate immune responses through multiple pathways."